0

543616

TLL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Trident Lifeline Limited Share Price Today

Investment Returns

Over 1 Month -7.92% Over 3 Months 0.91% Over 6 Months -17.13% Over 1 Year -6.08%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Trident Lifeline Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 291.60
  • P/E Ratio (TTM) 16.49
  • Beta -0.30
  • Book Value / share 83.03
  • Return on equity 22.04%
  • EPS (TTM) 15.16
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 6.01
info icon alternate text

Trident Lifeline Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 31.97
Operating Expense 0.00
Net Profit 6.01
Net Profit Margin (%) 18.79
Earnings Per Share (EPS) 5.04
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2025 (Values in Cr)
Revenue 23.67
Operating Expense 18.64
Net Profit 4.01
Net Profit Margin (%) 16.94
Earnings Per Share (EPS) 3.47
EBITDA 7.17
Effective Tax Rate (%) 32.26
Particulars SEP 2025 (Values in Cr)
Revenue 27.44
Operating Expense 22.07
Net Profit 4.94
Net Profit Margin (%) 18.00
Earnings Per Share (EPS) 4.26
EBITDA 7.49
Effective Tax Rate (%) 23.76
Particulars JUN 2025 (Values in Cr)
Revenue 18.82
Operating Expense 14.73
Net Profit 3.48
Net Profit Margin (%) 18.49
Earnings Per Share (EPS) 3.02
EBITDA 5.47
Effective Tax Rate (%) 24.83
Particulars MAR 2025 (Values in Cr)
Revenue 20.85
Operating Expense 16.45
Net Profit 4.35
Net Profit Margin (%) 20.86
Earnings Per Share (EPS) 3.79
EBITDA 7.18
Effective Tax Rate (%) 27.57
Particulars MAR 2026 (Values in Cr)
Revenue 101.90
Operating Expense 81.09
Net Profit 18.09
Net Profit Margin (%) 17.75
Earnings Per Share (EPS) 15.50
EBITDA 28.50
Effective Tax Rate (%) 27.58
Particulars MAR 2025 (Values in Cr)
Revenue 67.80
Operating Expense 53.04
Net Profit 13.05
Net Profit Margin (%) 19.24
Earnings Per Share (EPS) 11.35
EBITDA 20.67
Effective Tax Rate (%) 27.07
Particulars MAR 2024 (Values in Cr)
Revenue 44.65
Operating Expense 37.05
Net Profit 7.04
Net Profit Margin (%) 15.76
Earnings Per Share (EPS) 6.22
EBITDA 11.03
Effective Tax Rate (%) 28.16
Particulars MAR 2023 (Values in Cr)
Revenue 31.69
Operating Expense 26.27
Net Profit 6.01
Net Profit Margin (%) 18.96
Earnings Per Share (EPS) 6.22
EBITDA 7.40
Effective Tax Rate (%) 8.52
Particulars MAR 2022 (Values in Cr)
Revenue 21.77
Operating Expense 19.39
Net Profit 3.95
Net Profit Margin (%) 18.14
Earnings Per Share (EPS) 4.93
EBITDA 3.31
Effective Tax Rate (%) -32.21
Particulars MAR 2025 (Values in Cr)
Book Value / Share 56.05
ROE % 17.88
ROCE % 18.69
Total Debt to Total Equity 0.62
EBITDA Margin 26.74
Particulars MAR 2024 (Values in Cr)
Book Value / Share 45.14
ROE % 12.06
ROCE % 14.99
Total Debt to Total Equity 0.26
EBITDA Margin 23.10
Particulars MAR 2023 (Values in Cr)
Book Value / Share 39.69
ROE % 22.44
ROCE % 22.09
Total Debt to Total Equity 0.20
EBITDA Margin 23.45
Particulars MAR 2022 (Values in Cr)
Book Value / Share 5.97
ROE % 49.35
ROCE % 29.65
Total Debt to Total Equity 0.51
EBITDA Margin 15.25
Particulars MAR 2025 (Values in Cr)
Book Value / Share 57.16
ROE % 22.04
ROCE % 27.61
Total Debt to Total Equity 0.18
EBITDA Margin 30.69
Particulars MAR 2024 (Values in Cr)
Book Value / Share 45.81
ROE % 14.32
ROCE % 19.09
Total Debt to Total Equity 0.10
EBITDA Margin 24.82
Particulars MAR 2023 (Values in Cr)
Book Value / Share 39.68
ROE % 22.41
ROCE % 23.66
Total Debt to Total Equity 0.12
EBITDA Margin 23.41
Particulars MAR 2022 (Values in Cr)
Book Value / Share 5.97
ROE % 60.77
ROCE % 31.04
Total Debt to Total Equity 1.62
EBITDA Margin 15.25
Particulars MAR 2021 (Values in Cr)
Book Value / Share -0.94
ROE % 63.00
ROCE % 19.24
Total Debt to Total Equity 0.00
EBITDA Margin 14.66
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.46
Total Assets 156.00
Total Liabilities 156.00
Total Equity 69.64
Share Outstanding 1
Price to Book Ratio 4.50
Return on Assets (%) 7.53
Return on Capital (%) 9.5
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.65
Total Assets 87.07
Total Liabilities 87.07
Total Equity 53.95
Share Outstanding 1
Price to Book Ratio 3.58
Return on Assets (%) 7.28
Return on Capital (%) 8.77
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 13.77
Total Assets 62.57
Total Liabilities 62.57
Total Equity 47.10
Share Outstanding 1
Price to Book Ratio 4.01
Return on Assets (%) 9.61
Return on Capital (%) 10.98
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 13.83
Total Liabilities 13.83
Total Equity 4.77
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 28.53
Return on Capital (%) 54.61
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.11
Total Assets 97.79
Total Liabilities 97.79
Total Equity 65.72
Share Outstanding 1
Price to Book Ratio 4.50
Return on Assets (%) 13.34
Return on Capital (%) 16.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.00
Total Assets 73.23
Total Liabilities 73.23
Total Equity 52.67
Share Outstanding 1
Price to Book Ratio 3.58
Return on Assets (%) 9.61
Return on Capital (%) 11.96
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 13.76
Total Assets 56.49
Total Liabilities 56.49
Total Equity 45.63
Share Outstanding 1
Price to Book Ratio 4.01
Return on Assets (%) 10.64
Return on Capital (%) 12.27
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 13.82
Total Liabilities 13.82
Total Equity 4.77
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 28.55
Return on Capital (%) 54.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 11.44
Total Liabilities 11.44
Total Equity -0.47
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 5.52
Return on Capital (%) 15.59
Particulars MAR 2025 (Values in Cr)
Net Income 13.61
Cash from Operations -4.35
Cash from Investing -13.82
Cash from Financing 19.76
Net change in Cash -4.30
Free Cash Flow 6.74
Particulars MAR 2024 (Values in Cr)
Net Income 8.69
Cash from Operations 5.87
Cash from Investing -20.36
Cash from Financing 11.00
Net change in Cash -7.13
Free Cash Flow 23.76
Particulars MAR 2023 (Values in Cr)
Net Income 6.58
Cash from Operations -17.85
Cash from Investing -9.68
Cash from Financing 42.28
Net change in Cash 13.59
Free Cash Flow -10.93
Particulars MAR 2022 (Values in Cr)
Net Income 2.98
Cash from Operations -0.41
Cash from Investing -0.44
Cash from Financing 0.80
Net change in Cash 0.14
Free Cash Flow 0.04
Particulars MAR 2025 (Values in Cr)
Net Income 17.90
Cash from Operations 0.74
Cash from Investing -7.87
Cash from Financing 7.47
Net change in Cash -3.89
Free Cash Flow 5.96
Particulars MAR 2024 (Values in Cr)
Net Income 9.79
Cash from Operations 3.27
Cash from Investing -11.00
Cash from Financing 2.35
Net change in Cash -7.75
Free Cash Flow 12.35
Particulars MAR 2023 (Values in Cr)
Net Income 6.57
Cash from Operations -16.03
Cash from Investing -5.56
Cash from Financing 35.80
Net change in Cash 13.63
Free Cash Flow -13.76
Particulars MAR 2022 (Values in Cr)
Net Income 2.98
Cash from Operations -0.42
Cash from Investing -0.49
Cash from Financing 0.80
Net change in Cash 0.11
Free Cash Flow 0.03
Particulars MAR 2021 (Values in Cr)
Net Income 0.85
Cash from Operations 1.48
Cash from Investing -0.55
Cash from Financing -0.95
Net change in Cash -0.03
Free Cash Flow 2.04
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 13.39 1.56 248.29 23.12 38.85
BLISS GVS PHARMA LTD. 438.10 35.56 3.89 4646.32 118.35 462.70
CIPLA LTD. 1388.80 29.47 3.25 112193.56 1165.55 1672.20
FERMENTA BIOTECH LTD. 338.80 14.94 2.45 997.12 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 22.66 4.17 248.29 23.12 38.85
AMRUTAJAN HEALTH LTD 557.75 25.00 4.35 1612.49 490.00 789.95
ASTRAZENECA PHARMA IND LT 8243.90 107.66 23.61 20609.75 7630.00 10653.05
BLISS GVS PHARMA LTD. 438.10 47.26 4.02 4646.32 118.35 462.70

Trident Lifeline Limited shareholding pattern

Holding
29.64%
62.85%
7.24%
0.26%
6.9%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Trident Lifeline Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
244.35 -2.26 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 248.70
  • 26 Days 249.10
  • 10 Days 248.00
  • 50 Days 252.10
  • 12 Days 248.00
  • 100 Days 260.00
  • 20 Days 248.50
  • 200 Days 267.20
244.35 PIVOT
First Support 236.80 First Resistance 248.70 Second Support 232.45 Second Resistance 256.25 Third Support 224.90 Third Resistance 260.60
RSI 49.51 ADX 7.71 MACD -2.39 Williams % R -56.89 Commodity Channel Index (CCI) 59.66
Date 2026-06-12 Week 19600.00 Same Day 38400.00 Month 21548.00
1 Year -0.32 3 Year 0.34
Over 1 Month
-7.92% down
Over 1 Year
-6.08% down
Over 3 Months
0.91% down
Over 3 Years
20.52% down
Over 6 Months
-17.13% down
Over 5 Years
0.00% down

Trident Lifeline Limited Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Trident Lifeline Ltd?

Answer Field

Trident Lifeline Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 244.35 as on Jun 19 2026 03:28 PM.

What is the Market Cap of Trident Lifeline Ltd Share?

Answer Field

The market cap of Trident Lifeline Ltd for NSE ₹ 0.00 & for BSE ₹ 291.60 as on Jun 19 2026 03:28 PM.

What is the 52 Week High and Low of Trident Lifeline Ltd?

Answer Field

The 52 Week High and Low of Trident Lifeline Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 328.00 and ₹ 229.95.

What is 1 year return for Trident Lifeline Ltd?

Answer Field

The 1 year returns on the stock has been -7.40%.

What is the P/E Ratio of Trident Lifeline Ltd Share?

Answer Field

As on Jun 19 2026 03:28 PM the price-to-earnings (PE) ratio for Trident Lifeline Ltd share is 16.49.

What is the PB ratio of Trident Lifeline Ltd Share?

Answer Field

As on Jun 19 2026 03:28 PM, the price-to-book (PB) ratio for Trident Lifeline Ltd share is 83.03.

How to Buy Trident Lifeline Ltd Share?

Answer Field

You can trade in Trident Lifeline Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Trident Lifeline Ltd Share on Bajaj Broking App?

Answer Field

To buy Trident Lifeline Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Trident Lifeline Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|